204 related articles for article (PubMed ID: 15817921)
1. CXCR6 within T-helper (Th) and T-cytotoxic (Tc) type 1 lymphocytes in Graves' disease (GD).
Aust G; Kamprad M; Lamesch P; Schmücking E
Eur J Endocrinol; 2005 Apr; 152(4):635-43. PubMed ID: 15817921
[TBL] [Abstract][Full Text] [Related]
2. The role of CXCR5 and its ligand CXCL13 in the compartmentalization of lymphocytes in thyroids affected by autoimmune thyroid diseases.
Aust G; Sittig D; Becherer L; Anderegg U; Schütz A; Lamesch P; Schmücking E
Eur J Endocrinol; 2004 Feb; 150(2):225-34. PubMed ID: 14763921
[TBL] [Abstract][Full Text] [Related]
3. Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR).
Heuer M; Aust G; Ode-Hakim S; Scherbaum WA
Thyroid; 1996 Apr; 6(2):97-106. PubMed ID: 8733879
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease.
Fisfalen ME; Palmer EM; Van Seventer GA; Soltani K; Sawai Y; Kaplan E; Hidaka Y; Ober C; DeGroot LJ
J Clin Endocrinol Metab; 1997 Nov; 82(11):3655-63. PubMed ID: 9360522
[TBL] [Abstract][Full Text] [Related]
5. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease.
Nanba T; Watanabe M; Inoue N; Iwatani Y
Thyroid; 2009 May; 19(5):495-501. PubMed ID: 19415997
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease.
Morgan AJ; Guillen C; Symon FA; Huynh TT; Berry MA; Entwisle JJ; Briskin M; Pavord ID; Wardlaw AJ
Clin Exp Allergy; 2005 Dec; 35(12):1572-80. PubMed ID: 16393323
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease is associated with an altered CXCR3 and CCR5 expression in thyroid-derived compared to peripheral blood lymphocytes.
Aust G; Sittig D; Steinert M; Lamesch P; Lohmann T
Clin Exp Immunol; 2002 Mar; 127(3):479-85. PubMed ID: 11966764
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of regulated on activation, normal T cells expressed and secreted in thyroid tissue of patients with Graves' disease and thyroid autonomy and in thyroid-derived cell populations.
Simchen C; Lehmann I; Sittig D; Steinert M; Aust G
J Clin Endocrinol Metab; 2000 Dec; 85(12):4758-64. PubMed ID: 11134139
[TBL] [Abstract][Full Text] [Related]
9. IL-14 and IL-16 are expressed in the thyroid of patients with either Graves' disease or Hashimoto's thyroiditis.
Kemp EH; Ajjan RA; Metcalfe RA; Watson PF; Weetman AP
Clin Endocrinol (Oxf); 2015 Nov; 83(5):726-32. PubMed ID: 25940130
[TBL] [Abstract][Full Text] [Related]
10. Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's and Graves' disease.
Roura-Mir C; Catálfamo M; Sospedra M; Alcalde L; Pujol-Borrell R; Jaraquemada D
Eur J Immunol; 1997 Dec; 27(12):3290-302. PubMed ID: 9464817
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the role of Th0 and Th1 clones in autoimmune thyroid disease by use of Hu-SCID chimeras.
Fisfalen ME; Soltani K; Kaplan E; Palmer EM; van Seventer GA; Straus FH; Diaz M; Ober C; DeGroot LJ
Clin Immunol Immunopathol; 1997 Dec; 85(3):253-64. PubMed ID: 9400625
[TBL] [Abstract][Full Text] [Related]
12. Changes in expression of T-helper (Th) 1- and Th2-associated chemokine receptors on peripheral blood lymphocytes and plasma concentrations of their ligands, interferon-inducible protein-10 and thymus and activation-regulated chemokine, after antithyroid drug administration in hyperthyroid patients with Graves' disease.
Inukai Y; Momobayashi A; Sugawara N; Aso Y
Eur J Endocrinol; 2007 Jun; 156(6):623-30. PubMed ID: 17535861
[TBL] [Abstract][Full Text] [Related]
13. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.
Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555
[TBL] [Abstract][Full Text] [Related]
14. Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.
Ishikawa N; Eguchi K; Otsubo T; Ueki Y; Fukuda T; Tezuka H; Matsunaga M; Kawabe Y; Shimomura C; Izumi M
J Clin Endocrinol Metab; 1987 Jul; 65(1):17-23. PubMed ID: 2953751
[TBL] [Abstract][Full Text] [Related]
15. Different immunophenotype and autoantibody production by peripheral blood and thyroid-derived lymphocytes in patients with Graves' disease.
Aust G; Lehmann I; Heberling HJ
Exp Clin Endocrinol Diabetes; 1996; 104(1):50-8. PubMed ID: 8750571
[TBL] [Abstract][Full Text] [Related]
16. CD4+ T cells and the Th1/Th2 imbalance are implicated in the pathogenesis of Graves' ophthalmopathy.
Xia N; Zhou S; Liang Y; Xiao C; Shen H; Pan H; Deng H; Wang N; Li QQ
Int J Mol Med; 2006 May; 17(5):911-6. PubMed ID: 16596280
[TBL] [Abstract][Full Text] [Related]
17. Thyrocyte HLA-DR expression and interferon-gamma production in autoimmune thyroid disease.
Iwatani Y; Gerstein HC; Iitaka M; Row VV; Volpé R
J Clin Endocrinol Metab; 1986 Sep; 63(3):695-708. PubMed ID: 3090094
[TBL] [Abstract][Full Text] [Related]
18. Increased IL-21/IL-21R expression and its proinflammatory effects in autoimmune thyroid disease.
Guan LJ; Wang X; Meng S; Shi LF; Jiang WJ; Xiao L; Shi XH; Xu J; Zhang JA
Cytokine; 2015 Apr; 72(2):160-5. PubMed ID: 25647271
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of stromal-derived factor 1 in autonomous thyroid adenomas and its regulation in thyroid-derived cells.
Aust G; Steinert M; Kiessling S; Kamprad M; Simchen C
J Clin Endocrinol Metab; 2001 Jul; 86(7):3368-76. PubMed ID: 11443213
[TBL] [Abstract][Full Text] [Related]
20. Studies of CD4+ (helper/inducer) T lymphocytes in autoimmune thyroid disease: demonstration of specific induction in response to thyroid peroxidase (TPO) in vitro and its relationship with thyroid status in vivo.
Akasu F; Kasuga Y; Matsubayashi S; Carayon P; Volpé R
Thyroid; 1991; 1(3):215-22. PubMed ID: 1688100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
